NCT01541930View on ClinicalTrials.gov

An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours

PHASE3CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Malodorous Infected Cutaneous Ulcer

Interventions

DRUG

GK567

Once or twice daily, for 14 days, up to 30 g per day

Trial Locations (2)

Unknown

Galderma investigational site, Kanagawa

Galderma investigational site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY

NCT01541930 - An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours | Biotech Hunter | Biotech Hunter